Effect of topical interferon-γ gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk/+ mice
Authors:
- C VirtanenCVC Virtanen
- R E VerrallRVR E Verrall
- A RosenbergARA Rosenberg
- M FoldvariMFM Foldvari
- 10 November 2011
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 19 (10) , 978-987
Abstract
Scleroderma is a chronic disorder manifested by excessive synthesis and deposition of collagen in skin and connective tissue, vascular abnormalities, and autoimmunity. Using microarray and real-time PCR data, we show that intradermally expressed interferon γ (IFN-γ), generated after intradermal injection of IFN-γ-coding plasmid, and non-invasive topical nanoparticle (TNP) treatment with IFN-γ-coding plasmid, decreased collagen synthesis (via the Jak/Stat 1 pathway), upregulated Th1 cytokine levels, and downregulated the profibrotic cytokine Transforming growth factor β and the Smad pathways in the Tsk/+ (tight-skin scleroderma) mouse model. The TNP gene delivery system was constructed from gemini surfactant 16-3-16 and IFN-γ-coding plasmid. Topical administration of IFN-γ-coding plasmid in TNPs was effective in expressing IFN-γ levels after a 20-day treatment regimen without increased TLR4, CCL2, CCL11 and CCR2 mRNA levels that were observed in injected animals, signs considered to be innate responses to injury. The more uniform transgene IFN-γ expression caused significant (70-72%) collagen reduction, as assessed by reverse transcription real-time PCR. These results demonstrate efficient in vivo transfection using a gemini surfactant-based TNP delivery system able to modulate excessive collagen synthesis in scleroderma-affected skin.Keywords
This publication has 46 references indexed in Scilit:
- Safety, Tolerability, and Immunogenicity of InterferonsPharmaceuticals, 2010
- Molecular Pathogenesis of Skin Fibrosis: Insight from Animal ModelsCurrent Rheumatology Reports, 2010
- Correlation of mRNA and protein levels: Cell type-specific gene expression of cluster designation antigens in the prostateBMC Genomics, 2008
- Intracellular TGF-β Receptor Blockade Abrogates Smad-Dependent Fibroblast Activation In Vitro and In VivoJournal of Investigative Dermatology, 2006
- Analysis of the tight skin (Tsk1/+) mouse as a model for testing antifibrotic agentsLaboratory Investigation, 2005
- Interferon-γ Interferes with Transforming Growth Factor-β Signaling through Direct Interaction of YB-1 with Smad3Journal of Biological Chemistry, 2003
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Effect of IL-12 Encoding Plasmid Administration on Tight-Skin MouseBiochemical and Biophysical Research Communications, 2001
- Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized sclerodermaJournal of the American Academy of Dermatology, 1997
- The tight skin 2 mouseArthritis & Rheumatism, 1995